Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk

International Journal of Cancer

Volumn 124, Issue 2, 2009, Pages 440-442

  Lagiou, Pagona ^a,b   Georgila, Christina ^a   Samoli, Evangelia ^a   Lagiou, Areti ^a,c   Zourna, Pantelina ^a   Minaki, Ploumitsa ^a   Vassilarou, Dorothy ^d   Papadiamandis, Ioannis ^e   Sfikas, Constantinos ^e   Kalapothaki, Victoria ^a   Sekeris, Constantine E ^f   Trichopoulos, Dimitrios ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WEST ATTICA   (Greece)

^d Prolipsis Diagnostic Center   (Greece)

^e HELENA VENIZELOU HOSPITAL   (Greece)

^f INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Breast cancer; Estrogen; Progesterone; Receptors

Indexed keywords

ESTROGEN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; ESTROGEN RECEPTOR ALPHA;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; BIOSYNTHESIS; BREAST; BREAST DISEASE; BREAST TUMOR; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS; RISK;

ADULT; AGED; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; RISK;

EID: 58249084343     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23899     Document Type: Article

References (15)

1. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl JMed 1989;321:293-7.
2. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328-32.
3. Hankinson S, Tamimi R, Hunter D. Breast cancer. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of cancer epidemiology, 2nd edn. Oxford: Oxford Univeristy Press, 2008. 403-45.
4. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997;18:502-19.
5. Parl FF. Estrogens, estrogen receptor and breast cancer. Amsterdam: IOS Press, 2000. 57-110.
6. Khan SA, Rogers MA, Obando JA, Tamsen A. Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 1994;54:993-7.
7. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998;90:37-42.
8. Bernstein L, Press MF. Does estrogen receptor expression in normal breast tissue predict breast cancer risk? J Natl Cancer Inst 1998;90: 5-7.
9. Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopou-los D. Low oestrogen receptor α expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999;354: 1787-8.
10. Lawson JS, Field AS, Tran DD, Killeen J, Maskarenic G, Ishikura H, Trichopoulos D. Breast cancer incidence and estrogen receptor α in normal mammary tissue-an epidemiologic study among Japanese women in Japan and Hawaii. Int J Cancer 2002;97:685-7.
11. Anonymous. Hormone receptors and breast cancer. Br Med J 1976;2:67-8.
12. Wilbur DC, Willis J, Mooney RA, Fallon MA, Moynes R, di Sant Agnese PA. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunocytochemistry with the dextran-coated charcoal assay. Mod Pathol 1992;5:79-84.
13. Nichols GE, Frierson HF Jr, Boyd JC, Hanigan MH. Automated im-munohistochemical assay for estrogen receptor status in breast cancer using monoclonal antibody CC4-5 on the Ventana ES. Am J Clin Pathol 1996;106:332-8.
14. Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarty KS, Jr. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res 1989;49:1052-6.
15. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55-67.